.jpg){kind=link}
- Published
- Updated
Archived specimens may accelerate IVD evaluation, but availability does not establish representation of intended-use conditions. Selection, storage and accompanying clinical information influence interpretation. Treat the archive as more than a source of sample numbers.
Define the assessment
Explain why specimens entered the bank, their collection periods and populations, and processing and storage history. Examine when and how condition status was established. Describe questions for which prospective collection and archive evaluation may differ, without declaring one approach universally superior.
Worked example
For example, a bank preferentially retains positive specimens with high analyte levels. The new test performs well, but few borderline specimens exist. The team explains the selection pattern and missing range rather than presenting only overall success. It makes reasoned decisions about specimens with unknown thaw history.
Practical checks
- Compare archive-entry and study-selection criteria against source records.
- Assess adequacy of storage, thaw and remaining-volume information.
- Disclose missing clinical context and unrepresented specimen ranges.
Decision and limitations
Acceptance depends on explaining how much these specimens contribute to the claim. Disclose the archived source rather than presenting selected material as consecutive presentations. Determine additional evidence needs according to the importance of the limitation, and assess consent and permitted data use separately.
Frequently asked questions
- Can archived material provide clinical evidence?
- It can, with suitability, selection, handling and clinical context assessed against the evidence scope.
- Does a large archive eliminate selection concerns?
- No. Large numbers do not automatically fill systematically unrepresented conditions.